Pfizer Avoids Off-Label Marketing Suit Over Geodon, Zyvox

Law360, Washington (June 28, 2012, 6:06 PM EDT) -- A Texas federal judge on Thursday threw out a Blue Cross Blue Shield operator's off-label marketing suit claiming Pfizer Inc. misrepresented its antipsychotic drug Geodon and antibiotic Zyvox, saying the operator didn't show economic injury from Pfizer's actions.

District Judge Michael H. Schneider agreed with U.S. Magistrate Judge Caroline M. Craven, who recommended Health Care Services Corp.'s case be dismissed because it couldn't show that Pfizer's actions caused financial loss or caused doctors to prescribe the drugs for off-label use when they otherwise would not have....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Health Care Service Corporation v. Pfizer, Inc. et al


Case Number

2:10-cv-00221

Court

Texas Eastern

Nature of Suit

Racketeer/Corrupt Organization

Judge

Michael H. Schneider

Date Filed

July 2, 2010

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.